Best hospitals for CAR T Cell therapy in China
We work with the best hematology hospitals in China.
Peking University Cancer Hospital
Peking University Cancer Hospital, also known as Beijing Cancer Hospital, Beijing Institute for Cancer Research, and Peking University School of Oncology, is one of the leading academic cancer institutes in China. The hospital's clinicians deliver exceptional healthcare services, while its academic members responsible for translational research are highly regarded for their commitment to education and training.
Physicians at Peking University Cancer Hospital offer patient-centered medical services across a diverse range of cancer specializations, including, blood cancer, gastric cancer, breast cancer, lung cancer, colorectal cancer, liver cancer, esophageal carcinoma, lymphoma, melanoma, and other types of cancer. The composition of our team comprises a cohort of specialists hailing from many fields, encompassing oncology (the study and treatment of cancer), surgeons, radiology experts, and pathologists. This hospital is known for its pioneering work on CAR T-Cell therapy in China.
Beijing Gobroad Hospital
The renowned specialist possesses three decades of extensive internal clinical and laboratorial experience, with a particular focus on the domain of hematology. The department provides a range of diagnostic and therapeutic services for diseases affecting the hematological system, such as multiple myeloma, leukemia, lymphoma, thalassemia, coagulation disorders, and hematological tumors. It specializes in individualized treatment plans and integrated diagnosis for hematologic diseases.
Treatment options for hematologic tumors include CAR T-cell therapy, chemotherapy, immunotherapy, targeted therapy, demethylation, and radiotherapy. Furthermore, in order to ensure the safety and efficacy of medication use, our medical staff likewise modifies dosages in accordance with drug metabolism, genotype characteristics, and drug concentration monitoring. This hospital runs a lot of CAR T Cell therapy clinical trials in China.
Lu-Daopei Hospital, Beijing
Lu Daopei Hospital is specifically focused on the field of hematology. The hospital is named after Dr. Lu Daopei, a distinguished specialist in hematology and a trailblazer in Chinese bone marrow transplantation. Dr. Lu is also an esteemed academician at the Chinese Academy of Engineering. China now has two hospitals: Hebei Yanda Lu Daopei Hospital and Beijing Lu Daopei Hospital. Their clinical and research facilities offer a comprehensive range of diagnostic and therapeutic services for a variety of blood disorders. Offer hematopoietic stem cell transplantation (HSCT), CAR-T therapy, and therapeutic options for leukemia, lymphoma, and myeloma.
As of 2021, about 1100 participants have taken part in the CAR-T clinical trial at the facility. The rate of complete remission is approximately 90%. Additionally, we have made advancements in the field of CAR-T technology by implementing timely bridging to allo-HSCT. This approach effectively addresses the risk of relapse and enhances long-term survival rates. Recent T cell clinical trials have demonstrated significant efficacy.
Being one of the most active HSCT centers, the HSCT department carries out 10% of the total HSCT cases in China annually. They have successfully performed over 7,000 HSCT procedures, with more than 4800 of them being haplo-HSCT cases. This hospital has done the maximum number of CAR T Cell treatment in China till date.
.
Shenzen Southern University Medical University Hospital
Shenzhen Southern Medical University Hospital covers an area of 500,000 square meters, with a total planned bed capacity of 2,500 and its own clinical medical school and clinical research institute. The hospital has gradually introduced renowned experts and experienced professors from both domestic and international backgrounds. Significant breakthroughs have been made in medical core technologies in fields such as Gastroenterology, Neurology, General Surgery, Orthopedics, Dermatology, Cosmetology & Venereology, Otorhinolaryngology (Pediatric Otorhinolaryngology), and Nursing Studies.
The gastroenterology department was nominated for the 2017 Southern China Hospital Specialist Reputation Ranking [Fudan University Edition], being the only hospital selected from Shenzhen. Additionally, Shenzhen Hospital recruited 10 "Sanming Project" teams comprising domestic and international technical experts, which has enhanced the level of medical technology.
Shenzhen Hospital has obtained accreditation as a Guangdong Chest Pain Center and has become a member of the National Stroke Center. The success rate of ECMO withdrawal has reached 70%, and the success rate of rescuing within 28 days has reached 55%, setting a good example for emergency and intensive care treatment in Shenzhen.
